*P65812A0132*
Turn over    
Candidate surname
Other names
Total Marks
Centre Number
Candidate Number
Please check the examination details below before entering your candidate information
Time
Paper
reference
P65812A
©2021 Pearson Education Ltd.
1/1/1/1/1/1/1/
Instructions
•	Use black ink or ball-point pen.
•	Fill in the boxes at the top of this page with your name,  
centre number and candidate number.
•	Answer all questions.
•	Answer the questions in the spaces provided  
– there may be more space than you need.
•	Show all your working in calculations and include units where appropriate.
Information
•	The total mark for this paper is 80. 
•	The marks for each question are shown in brackets  
– use this as a guide as to how much time to spend on each question. 
•	In questions marked with an asterisk (*), marks will be awarded for your ability to 
structure your answer logically, showing how the points that you make are related or 
follow on from each other where appropriate.
Advice
•	Read each question carefully before you start to answer it.
•	Try to answer every question.
•	Check your answers if you have time at the end.
•	Good luck with your examination.
You must have:
Scientific calculator, ruler, HB pencil
Biology
International Advanced Subsidiary / Advanced Level
UNIT 1: Molecules, Diet, Transport and Health
WBI11/01
1 hour 30 minutes
Pearson Edexcel 
International
Advanced Level
PMT


--- Page Break ---

*P65812A0232*
2
	
Answer ALL questions. Write your answers in the spaces provided.
Some questions must be answered with a cross in a box . If you change your mind about an 
answer, put a line through the box 
 and then mark your new answer with a cross .
1	 Polysaccharides, lipids, nucleic acids and proteins are large molecules found in living 
organisms.
	
(a)	 Polymers are large molecules made of monomers. The table gives information 
about some of these polymers.
	
	
Complete the table by filling in the empty boxes with either the name of the 
monomer, the elements present in each monomer or the type of bond between 
monomers.
(4)
Polymer
Monomer
Elements present in 
monomer
Type of bond between 
monomers
polysaccharides 
monosaccharide
...................................................................
...................................................................
...................................................................
...................................................................
...................................................................
glycosidic
nucleic acid
...................................................................
carbon, hydrogen, 
oxygen, phosphorus and 
nitrogen
...................................................................
protein
amino acid
...................................................................
...................................................................
...................................................................
...................................................................
...................................................................
peptide
PMT


--- Page Break ---

*P65812A0332*
Turn over    
3
	
	
(b)	 Triglycerides are lipids.
	
	
Describe how an unsaturated triglyceride is synthesised.
(3)
....................................................................................................................................................................................................................................................................................
....................................................................................................................................................................................................................................................................................
....................................................................................................................................................................................................................................................................................
....................................................................................................................................................................................................................................................................................
....................................................................................................................................................................................................................................................................................
....................................................................................................................................................................................................................................................................................
....................................................................................................................................................................................................................................................................................
....................................................................................................................................................................................................................................................................................
....................................................................................................................................................................................................................................................................................
(Total for Question 1 = 7 marks)
PMT


--- Page Break ---

*P65812A0432*
4
	
2	 A person with diabetes has a blood glucose level that can be too high.
	
When the blood glucose level of a person without diabetes becomes too high, the 
liver stores glucose as a polysaccharide.
	
(a)	 Which polysaccharide does the liver store?
(1)
	
A	 amylopectin
	
B	 cellulose
	
C	 glycogen
	
D	 starch
	
(b)	 Blood glucose levels can become high following the digestion of carbohydrates.
	
	
Which of the following can be digested to release glucose?
(1)
	
A	 both fructose and sucrose
	
B	 both fructose and galactose
	
C	 both galactose and lactose
	
D	 both lactose and sucrose
	
(c)	 Diabetes is a risk factor for cardiovascular disease.
	
	
(i)	 One estimate is that there are 415 million people with diabetes in the world	
and that 46% of these people are undiagnosed.
	
	
	
Calculate the number of people who have undiagnosed diabetes.
(1)
Answer ..............................................................
PMT


--- Page Break ---

*P65812A0532*
Turn over    
5
	
	
	
(ii)	 There are two types of diabetes, Type I and Type II.
	
	
	
The treatment for Type I diabetes is different from the treatment for Type II 
diabetes, so it is important for a correct diagnosis to be made.
	
	
	
Diagnosis can be difficult, particularly in people aged between 20 and 40 years old.
	
	
	
A genetic screening method is now available for the diagnosis of diabetes.
	
	
	
Explain why doctors are more likely to screen individuals once they develop 
diabetes than use methods such as prenatal testing.
(3)
....................................................................................................................................................................................................................................................................................
....................................................................................................................................................................................................................................................................................
....................................................................................................................................................................................................................................................................................
....................................................................................................................................................................................................................................................................................
....................................................................................................................................................................................................................................................................................
....................................................................................................................................................................................................................................................................................
....................................................................................................................................................................................................................................................................................
....................................................................................................................................................................................................................................................................................
....................................................................................................................................................................................................................................................................................
(Total for Question 2 = 6 marks)
PMT


--- Page Break ---

*P65812A0632*
6
	
BLANK PAGE
PMT


--- Page Break ---

*P65812A0732*
Turn over    
7
	
3	 Stents are used in the treatment of atherosclerosis.
	
(a)	 The diagram shows how stents are positioned in a diseased coronary artery.
plaque
stent
An uninflated balloon and narrow 
stent are inserted into the diseased 
coronary artery.
The balloon is inflated, expanding the 
stent.
The balloon is deflated and removed, 
leaving the expanded stent in place.
balloon
	
	
Explain why a stent is used in the treatment of atherosclerosis in a coronary artery.
(3)
....................................................................................................................................................................................................................................................................................
....................................................................................................................................................................................................................................................................................
....................................................................................................................................................................................................................................................................................
....................................................................................................................................................................................................................................................................................
....................................................................................................................................................................................................................................................................................
....................................................................................................................................................................................................................................................................................
....................................................................................................................................................................................................................................................................................
....................................................................................................................................................................................................................................................................................
....................................................................................................................................................................................................................................................................................
PMT


--- Page Break ---

*P65812A0832*
8
	
	
(b)	 Inserting a stent can damage the artery.
	
	
This damage can result in stent thrombosis if the blood clotting process is 
stimulated.
	
	
A study looked at the damage caused by two different types of stent, stent A and 
stent B.
	
	
The graph shows the incidence of stent thrombosis found in this study.
Incidence 
of stent 
thrombosis 
(%)
0
2.0
1.0
0.0
1
2
3
stent A
Years after inserting the stent
stent B
	
	
(i)	 In this study, 800 patients had stent A inserted and 400 patients had stent B 
inserted.
	
	
	
Calculate the difference in the number of patients who developed stent	
thrombosis three years after inserting the stent.
(2)
Answer ..............................................................
PMT


--- Page Break ---

*P65812A0932*
Turn over    
9
	
	
	
(ii)	 State how the formation of a blood clot in the coronary artery could cause the 
death of the patient.
(1)
....................................................................................................................................................................................................................................................................................
....................................................................................................................................................................................................................................................................................
....................................................................................................................................................................................................................................................................................
	
	
(iii)	Which components of the blood clotting process are enzymes in their 
active form?
(1)
	
A	 prothrombin and thromboplastin only
	
B	 prothrombin and thrombin only
	
C	 prothrombin, thrombin and thromboplastin
	
D	 thrombin and thromboplastin only
	
	
(iv)	Which components of the blood clotting process are soluble in blood plasma?
(1)
	
A	 fibrin and fibrinogen
	
B	 fibrin and thromboplastin
	
C	 fibrinogen and thromboplastin
	
D	 fibrinogen only
	
	
(v)	 Stent B contains a drug to prevent stent thrombosis.
	
	
	
Suggest one type of drug that could be used in stent B.
(1)
....................................................................................................................................................................................................................................................................................
(Total for Question 3 = 9 marks)
PMT


--- Page Break ---

*P65812A01032*
10
	
4	 Phenylthiocarbamide (PTC) is a chemical that has a very bitter taste to some 
individuals	(tasters).
	
The ability to taste PTC is determined by a gene that codes for a bitter‑taste receptor 
on	 the tongue.
	
The pedigree diagram shows some of the tasters and non‑tasters in a family.
1
8
2
9
3
4
5
6
7
Key
	 male taster 
	
female taster 
	
male non-taster 
	
female non-taster
	
(a)	 Complete the diagram to show the following information:
(1)
•	
individual 7 as a male taster
•	
individual 8 as a male non‑taster
•	
individual 9 as a female taster.
PMT


--- Page Break ---

*P65812A01132*
Turn over    
11
	
	
(b)	 Describe the difference between each of the following pairs of terms, using the 
information in the pedigree diagram to illustrate your answer.
	
	
(i)	 Gene and allele
(2)
....................................................................................................................................................................................................................................................................................
....................................................................................................................................................................................................................................................................................
....................................................................................................................................................................................................................................................................................
....................................................................................................................................................................................................................................................................................
....................................................................................................................................................................................................................................................................................
....................................................................................................................................................................................................................................................................................
	
	
(ii)	 Genotype and phenotype
(2)
....................................................................................................................................................................................................................................................................................
....................................................................................................................................................................................................................................................................................
....................................................................................................................................................................................................................................................................................
....................................................................................................................................................................................................................................................................................
....................................................................................................................................................................................................................................................................................
....................................................................................................................................................................................................................................................................................
	
(c)	 Explain which is the dominant allele.
	
	
Use the information in the pedigree diagram to support your answer.
(2)
....................................................................................................................................................................................................................................................................................
....................................................................................................................................................................................................................................................................................
....................................................................................................................................................................................................................................................................................
....................................................................................................................................................................................................................................................................................
....................................................................................................................................................................................................................................................................................
....................................................................................................................................................................................................................................................................................
PMT


--- Page Break ---

*P65812A01232*
12
	
	
(d)	 Explain why this gene is unlikely to be located on the X chromosome.
	
	
Use the information in the pedigree diagram to support your answer.
(2)
....................................................................................................................................................................................................................................................................................
....................................................................................................................................................................................................................................................................................
....................................................................................................................................................................................................................................................................................
....................................................................................................................................................................................................................................................................................
....................................................................................................................................................................................................................................................................................
....................................................................................................................................................................................................................................................................................
(Total for Question 4 = 9 marks)
PMT


--- Page Break ---

*P65812A01332*
Turn over    
13
	
BLANK PAGE
PMT


--- Page Break ---

*P65812A01432*
14
	
5	 People with cystic fibrosis produce very thick, sticky mucus.
	
Cystic fibrosis is caused by mutations in a gene coding for the CFTR protein.
	
(a)	 Explain why a mutation in this gene results in the production of very thick, 
sticky mucus.
(3)
....................................................................................................................................................................................................................................................................................
....................................................................................................................................................................................................................................................................................
....................................................................................................................................................................................................................................................................................
....................................................................................................................................................................................................................................................................................
....................................................................................................................................................................................................................................................................................
....................................................................................................................................................................................................................................................................................
....................................................................................................................................................................................................................................................................................
....................................................................................................................................................................................................................................................................................
....................................................................................................................................................................................................................................................................................
PMT


--- Page Break ---

*P65812A01532*
Turn over    
15
	
	
(b)	 The diagram shows some health problems associated with cystic fibrosis, in a female.
problems 
absorbing 
nutrients
breathing 
difficulties
infertility
	
	
Explain why very thick, sticky mucus results in these health problems.
(5)
....................................................................................................................................................................................................................................................................................
....................................................................................................................................................................................................................................................................................
....................................................................................................................................................................................................................................................................................
....................................................................................................................................................................................................................................................................................
....................................................................................................................................................................................................................................................................................
....................................................................................................................................................................................................................................................................................
....................................................................................................................................................................................................................................................................................
....................................................................................................................................................................................................................................................................................
....................................................................................................................................................................................................................................................................................
....................................................................................................................................................................................................................................................................................
....................................................................................................................................................................................................................................................................................
....................................................................................................................................................................................................................................................................................
....................................................................................................................................................................................................................................................................................
....................................................................................................................................................................................................................................................................................
....................................................................................................................................................................................................................................................................................
PMT


--- Page Break ---

*P65812A01632*
16
	
	
(c)	 The graph shows the correlation between the concentration of chloride ions in 
sweat and the level of function of the CFTR protein.
Concentration 
of chloride 
ions in sweat 
/ mmol dm–3
   Level of function of the CFTR protein (%)
100
80
60
40
20
0
100
80
60
40
20
0
	
	
Individuals diagnosed with cystic fibrosis have a level of function of the CFTR 
protein of 18% or less.
	
	
(i)	 Which is the change in concentration of chloride ions in the sweat of an 
individual when the level of function of CFTR protein decreased from 100% 
to 18%?
(1)
	
A	 15 mmol dm–3
	
B	 35 mmol dm–3
	
C	 40 mmol dm–3
	
D	 80 mmol dm–3
PMT


--- Page Break ---

*P65812A01732*
Turn over    
17
	
	
	
(ii)	 Cystic fibrosis results from different mutations in the CFTR gene.
	
	
	
Explain how the graph provides evidence that cystic fibrosis results from 
different mutations in the CFTR gene.
(2)
....................................................................................................................................................................................................................................................................................
....................................................................................................................................................................................................................................................................................
....................................................................................................................................................................................................................................................................................
....................................................................................................................................................................................................................................................................................
....................................................................................................................................................................................................................................................................................
....................................................................................................................................................................................................................................................................................
(Total for Question 5 = 11 marks)
PMT


--- Page Break ---

*P65812A01832*
18
	
6	 Obesity increases the risk of cardiovascular disease (CVD).
	
Body mass index (BMI), waist‑to‑hip ratio (WHR) and skinfold thickness are indicators 
of obesity.
	
(a)	 The table shows some measurements taken from two females, female J and 
female K.
Female
Height / cm
Mass / kg
Waist / cm
Hips / cm
BMI
WHR
J
155
59.1
80
100
25
0.80
K
155
125
36
0.80
	
	
(i)	 Calculate the waist size of female K.
(1)
Answer .............................................................. cm
	
	
(ii)	 The formula for calculating BMI is:
BMI = 
mass in kg
(height in m)2
	
	
	
Calculate the mass of female K, using the data in the table.
(3)
Answer .............................................................. kg
PMT


--- Page Break ---

*P65812A01932*
Turn over    
19
	
	
	
(iii)	Comment on the risk of developing CVD in these two women.
(2)
....................................................................................................................................................................................................................................................................................
....................................................................................................................................................................................................................................................................................
....................................................................................................................................................................................................................................................................................
....................................................................................................................................................................................................................................................................................
....................................................................................................................................................................................................................................................................................
....................................................................................................................................................................................................................................................................................
	
	
(iv)	The diagram shows how the waist and hip measurements should be taken, 
using a tape measure.
measure hips at widest point
measure waist at narrowest point
	
	
	
Explain how the way a person takes these measurements could produce an 
underestimate of their risk of CVD.
(2)
....................................................................................................................................................................................................................................................................................
....................................................................................................................................................................................................................................................................................
....................................................................................................................................................................................................................................................................................
....................................................................................................................................................................................................................................................................................
....................................................................................................................................................................................................................................................................................
....................................................................................................................................................................................................................................................................................
PMT


--- Page Break ---

*P65812A02032*
20
	
	
(b)	 The diagram shows how a skinfold thickness measurement is taken over the 
triceps muscle at the back of the arm.
skin callipers are placed across 
the skinfold and the thickness 
read from a scale
the skin is pinched over the 
triceps to form a skinfold
	
	
Skinfold thickness measures the thickness of the layer of fat under the skin.
	
	
Measurements are taken from several sites on the body.
	
	
The table shows the skinfold thickness at four sites on a 42-year-old female.
Site
Skinfold thickness / a.u.
over the biceps at the front of the arm
0.63
over the triceps at the back of the arm
0.82
under the shoulder blade at the back of the neck
0.65
above the hip bone at the side of the body
0.82
	
	
(i)	 Suggest two reasons why the skinfold thickness values are different at each 
site on the body.
	
	
	
Assume that the skin callipers have been used correctly.
(2)
....................................................................................................................................................................................................................................................................................
....................................................................................................................................................................................................................................................................................
....................................................................................................................................................................................................................................................................................
....................................................................................................................................................................................................................................................................................
....................................................................................................................................................................................................................................................................................
....................................................................................................................................................................................................................................................................................
PMT


--- Page Break ---

*P65812A02132*
Turn over    
21
	
	
	
(ii)	 The table shows a body fat interpretation chart.
	
	
	
The values in the table are the means of the four skinfold thickness 
measurements.
Age
Level of body fat
Low
Moderate
High
Very high
20 to 29
<0.71
0.71 to 0.77
0.78 to 0.82
>0.82
30 to 39
<0.72
0.72 to 0.78
0.79 to 0.84
>0.84
40 to 49
<0.73
0.73 to 0.79
0.80 to 0.87
>0.87
50 to 59
<0.74
0.74 to 0.81
0.82 to 0.88
>0.88
	
Determine the level of body fat of this female.
(1)
Answer ..............................................................
(Total for Question 6 = 11 marks)
PMT


--- Page Break ---

*P65812A02232*
22
	
7	 A number of diseases are associated with lifestyle risk factors.
	
Some of these risk factors cause mutations.
	
(a)	 Mutations can give rise to cancer.
	
	
State the meaning of the term mutation.
(1)
....................................................................................................................................................................................................................................................................................
....................................................................................................................................................................................................................................................................................
....................................................................................................................................................................................................................................................................................
	
(b)	 Exposure to ultraviolet light is associated with the development of skin cancer.
	
	
The graphs show the incidence of skin cancer in males and females in one 
country in the Far East, from 2000 to 2005.
Incidence of 
skin cancer per 
100 000 of the male 
population
Age / years
250
200
150
100
50
0
0–9
10–19 20–29 30–39 40–49 50–59 60–69 70–79
>80
2000
2001
2002
2003
2004
2005
Incidence of skin 
cancer per 100 000 
of the female 
population
150
100
50
0
2001
2000
2002
2003
2004
2005
Age / years
0–9
10–19 20–29 30–39 40–49 50–59 60–69 70–79
>80
PMT


--- Page Break ---

*P65812A02332*
Turn over    
23
	
	
	
(i)	 The graphs show some correlations.
	
	
	
State the meaning of the term correlation.
(1)
....................................................................................................................................................................................................................................................................................
....................................................................................................................................................................................................................................................................................
....................................................................................................................................................................................................................................................................................
	
	
(ii)	 Describe the correlations shown by these graphs.
(3)
....................................................................................................................................................................................................................................................................................
....................................................................................................................................................................................................................................................................................
....................................................................................................................................................................................................................................................................................
....................................................................................................................................................................................................................................................................................
....................................................................................................................................................................................................................................................................................
....................................................................................................................................................................................................................................................................................
....................................................................................................................................................................................................................................................................................
....................................................................................................................................................................................................................................................................................
....................................................................................................................................................................................................................................................................................
	
	
(iii)	Suggest a reason for each of the correlations shown by these graphs.
(3)
....................................................................................................................................................................................................................................................................................
....................................................................................................................................................................................................................................................................................
....................................................................................................................................................................................................................................................................................
....................................................................................................................................................................................................................................................................................
....................................................................................................................................................................................................................................................................................
....................................................................................................................................................................................................................................................................................
....................................................................................................................................................................................................................................................................................
....................................................................................................................................................................................................................................................................................
....................................................................................................................................................................................................................................................................................
PMT


--- Page Break ---

*P65812A02432*
24
	
	
*(c)	 The table shows some information from a study of the incidence of emphysema 
in smokers and non‑smokers.
Information
Males
Females
Number of individuals in the study
25
25
Mean age when diagnosed / years
53.1
54.2
Range of ages when diagnosed / years
32 to 77
34 to 68
Number of smokers
5
6
Number of non‑smokers
20
19
Number of smokers with emphysema
1
6
Number of non‑smokers with emphysema
0
0
	
	
Criticise the design of this study.
(6)
....................................................................................................................................................................................................................................................................................
....................................................................................................................................................................................................................................................................................
....................................................................................................................................................................................................................................................................................
....................................................................................................................................................................................................................................................................................
....................................................................................................................................................................................................................................................................................
....................................................................................................................................................................................................................................................................................
....................................................................................................................................................................................................................................................................................
....................................................................................................................................................................................................................................................................................
....................................................................................................................................................................................................................................................................................
....................................................................................................................................................................................................................................................................................
....................................................................................................................................................................................................................................................................................
....................................................................................................................................................................................................................................................................................
....................................................................................................................................................................................................................................................................................
....................................................................................................................................................................................................................................................................................
PMT


--- Page Break ---

*P65812A02532*
Turn over    
25
	
....................................................................................................................................................................................................................................................................................
....................................................................................................................................................................................................................................................................................
....................................................................................................................................................................................................................................................................................
....................................................................................................................................................................................................................................................................................
(Total for Question 7 = 14 marks)
PMT


--- Page Break ---

*P65812A02632*
26
	
8	 The structure of the cell membrane affects the properties of the cell membrane.
	
The diagram shows the structure of part of a cell membrane.
protein
Q
R
S
T
	
(a)	 (i)	 The magnification of this diagram is 1 × 107.
	
	
	
The structure labelled T is 2 units long.
	
	
	
What is this unit?
(1)
	
A	 cm
	
B	 mm
	
C	 µm
	
D	 nm
	
	
(ii)	 Which structures contain a phosphate group?
(1)
	
A	 Q and R
	
B	 Q and T
	
C	 R and S
	
D	 S and T
	
(iii)	Which ratio of the structures affects the fluidity of this membrane?
(1)
	
A	 Q : T
	
B	 R : Q
	
C	 R : T
	
D	 S : T
PMT


--- Page Break ---

*P65812A02732*
Turn over    
27
	
	
(b)	 Explain the role of the primary structure in determining the properties of the 
protein labelled in the diagram.
(4)
....................................................................................................................................................................................................................................................................................
....................................................................................................................................................................................................................................................................................
....................................................................................................................................................................................................................................................................................
....................................................................................................................................................................................................................................................................................
....................................................................................................................................................................................................................................................................................
....................................................................................................................................................................................................................................................................................
....................................................................................................................................................................................................................................................................................
....................................................................................................................................................................................................................................................................................
....................................................................................................................................................................................................................................................................................
....................................................................................................................................................................................................................................................................................
....................................................................................................................................................................................................................................................................................
....................................................................................................................................................................................................................................................................................
PMT


--- Page Break ---

*P65812A02832*
28
	
	
*(c)	 The diagram and table give information about some molecules found inside and 
outside a cell.
Molecule
Key
Description
E
small dipolar molecule consisting of two 
hydrogen atoms and one oxygen atom
F
large polar molecule
G
non‑polar molecule
H
small polar molecule
outside a cell
cell membrane
inside a cell
PMT


--- Page Break ---

*P65812A02932*
29
	
	
	
Explain why each of these molecules enters the cell by a different mechanism.
	
	
Use the information in the table and the diagram to support your answer.
(6)
....................................................................................................................................................................................................................................................................................
....................................................................................................................................................................................................................................................................................
....................................................................................................................................................................................................................................................................................
....................................................................................................................................................................................................................................................................................
....................................................................................................................................................................................................................................................................................
....................................................................................................................................................................................................................................................................................
....................................................................................................................................................................................................................................................................................
....................................................................................................................................................................................................................................................................................
....................................................................................................................................................................................................................................................................................
....................................................................................................................................................................................................................................................................................
....................................................................................................................................................................................................................................................................................
....................................................................................................................................................................................................................................................................................
....................................................................................................................................................................................................................................................................................
....................................................................................................................................................................................................................................................................................
....................................................................................................................................................................................................................................................................................
....................................................................................................................................................................................................................................................................................
....................................................................................................................................................................................................................................................................................
....................................................................................................................................................................................................................................................................................
(Total for Question 8 = 13 marks)
TOTAL FOR PAPER = 80 MARKS
PMT


--- Page Break ---

*P65812A03032*
30
	
BLANK PAGE
PMT


--- Page Break ---

*P65812A03132*
31
	
BLANK PAGE
PMT


--- Page Break ---

*P65812A03232*
32
	
BLANK PAGE
PMT
